Tenmile — Full Portfolio
39 tracked investments · listed companies and verified rows first
Aravax is a clinical-stage biotechnology company developing next-generation immunotherapies to treat food allergies.
BiotechHealthtechMedical DevicesMelbourne, AU
Sara Prickett(Co-founder)in
Co-investorsNovartis Venture FundBreakthrough VictoriaUniSeed Pty Ltd.
Revagenix is a precision-therapeutics company that develops drugs for serious chronic diseases, starting from the underlying biology and unmet clinical needs.
BiotechDeep TechHealthtechMedical Devices
Ryan Cirz(Co-founder & CEO)inAndrew McCandlish(Co-founder & COO)inPeter Smith(Chief Scientific Officer)inDaniel Cloutier(VP, Development)in
Co-investorsNovo Holdings
AdvanCell is a clinical-stage radiopharmaceutical company developing a pipeline of targeted alpha therapies for the treatment of cancers including prostate, melanoma, ovarian, breast, and lung.
BiotechHealthtechMedical DevicesCambridge, US
Andrew Adamovich(Director)inPhilina Lee(Executive Officer, Director)inAaron Pickett(Executive Officer)in
BoardWing Cheong Lam(Director)Nik Economopoulos(Director)Anthony Aiudi(Director)
Co-investorsBain Capital Life SciencesCatalio Capital Management, LPProto AxiomSV Health InvestorsAbingworthAlly Bridge Group+2 more
Amaroq Therapeutics develops first-in-class therapies targeting long non-coding RNAs (lncRNAs) implicated in oncology and other diseases.
Biotech
Co-investorsBooster Innovation FundCure Kids VenturesBrandon Capital Partners
Antares Therapeutics discovers and develops precision medicines, with a focus on small molecule therapies targeting previously undruggable oncology targets and other serious diseases.
AI & Machine LearningBiotechMedical DevicesCambridge, US
Adam Friedman(Chief Executive Officer)inAndrew Fedder(Executive Officer, Director)inBrian Piper(Executive Officer, Director)in
Co-investorsAtlas VentureLightspeed Venture PartnersVida VenturesOmega FundsAbingworthAlleyCorp+1 more
AusBiotech is the national industry association representing Australia's life sciences ecosystem, advocating for policy, facilitating connections, and supporting growth for biotechnology, medical technologies, and digital health companies.
BiotechDigital HealthMedical DevicesBrisbane, AU
Carina Biotech develops chimeric antigen receptor T cell (CAR-T) therapies and other adoptive cell therapies to treat solid cancers using a patient's immune system.
BiotechDigital HealthHealthtechMedical DevicesAdelaide, AU
Simon Barry(Chief Medical Scientist)inDr Deborah Rathjen(Chief Executive Officer & Managing Director)Professor Shaun McColl(Chief Scientific Officer)
BoardClaudine Bonder(Head, Vascular Biology and Cell Trafficking Laboratory)
Creyon develops aptamer-delivered oligonucleotide therapeutics for targeted cell-specific delivery, including small interfering RNA and antisense oligonucleotides.
AI & Machine LearningBiotechDeep Tech
Matthew Levy(Co-founder)in
Co-investorsLux CapitalDCVC Bio
Creyon develops cell-specific therapeutics using aptamer-delivered oligonucleotides, engineering aptamers to deliver therapeutic payloads to immune cells and across the blood-brain barrier for immune-driven and CNS diseases, plus a splice-switching oligonucleotide program for late-onset Pompe disease.
AI & Machine LearningBiotechDeep Tech
Co-investorsBioBritDCVC (Data Collective)DCVC BioAlexandriaCasdin CapitalLux Capital
CurveBeam AI develops point-of-care cone beam CT imaging systems combined with AI and deep learning tools for orthopedic and bone health applications, including fragility fracture prevention.
AI & Machine LearningHealthtechMedical DevicesHatfield, US
Clinical services company collecting patient data and developing novel drug and care models, including MDMA-assisted treatment for PTSD.
Luma provides a platform for creating event pages, sending invitations, and selling tickets for events.
SaaS
Victor Pontis(Founder)in
Co-investorsAllen Institute for AI (AI2) IncubatorAmplify PartnersBerkley Center for EntrepreneurshipBethnal Green VenturesCedar CapitalEIT Urban Mobility Accelerator+13 more
Humanitix operates a non-profit ticketing platform for event hosts and attendees, transforming booking fees into charitable donations for education, healthcare, and social causes worldwide.
ConsumerImpact & Social GoodMarketplacesSaaSSocialPhiladelphia, US
Adam McCurdie(Co-founder)inJoshua Ross(Co-founder)Josh(Co-founder)
Inventia Life Science provides RASTRUM Workflow Paths, tools for generating reproducible 3D cell models for research and drug discovery.
AI & Machine LearningBiotechDeep TechMedical Devices
Co-investorsMain Sequence VenturesVU Venture PartnersBlackbird VenturesSkip Capital
Kantoko operates a telehealth platform connecting adults with ADHD specialists for remote diagnosis and treatment planning in Australia.
Digital HealthHealthtechMental HealthAustralia, AU
Co-investorsSide Stage Ventures
LimmaTech develops vaccine technologies and programs designed to combat antimicrobial-resistant pathogens and prevent severe infections.
AI & Machine LearningBiotechHealthtechMedical Devices
Co-investorsAdjuvant CapitalAndera PartnersNovo Holdings
Lumos Diagnostics develops rapid point-of-care diagnostic tests and digital reader platforms for healthcare professionals, targeting infectious and inflammatory diseases.
AI & Machine LearningBiotechDigital HealthHealthtechMedical Devices
Doug Ward(CEO)inPaul Kase(Chief Commercial Officer)in
BoardSam Lanyon(Non-Executive Chair)
Mindset is a daily wellness and self-care app featuring audio collections and stories from celebrities and experts.
ConsumerMental HealthWellness & FitnessKing Of Prussia, US
April J Perrymore(Executive Officer, Director, Promoter)Darlene Link(Executive Officer, Director, Promoter)
Co-investorsA.Capital Venturesalphabet angelsTq Ventures LlcUnion Square Ventures (USV)Banana CapitalGold House Ventures+3 more
Mindset Health develops digital health programs using hypnotherapy and mind-body medicine to help patients manage gastrointestinal disorders and improve health outcomes.
Digital HealthHealthtechMedical DevicesMental HealthWellness & FitnessMelbourne, AU
Alex Naoumidis(Co-founder & Co-CEO)inChris Naoumidis(Founder)in
Co-investorsAlberts Impact VenturesFifty YearsKing River CapitalPerennial PartnersY CombinatorAfore Capital+5 more
Oncko develops machine learning and experimental platforms to discover optimized multi-drug cancer treatment combinations by screening against resistance mechanisms.
AI & Machine LearningBiotechDeep Tech
Atray Dixit(Co-founder, CEO)inBill Grossman(Co-founder, Strategic Advisor)in
Co-investorsAdverb VenturesIllumina Ventures
Perx develops a digital health platform that uses engagement and behavioral incentive techniques to help older patients, those with chronic conditions, and underserved populations adhere to their treatment plans and manage their health.
Digital HealthHealthtechSaaSAustralia / USA
Hugo Rourke(CEO & Co-founder)inScott(COO & Co-founder)
Co-investorsAirTree VenturesTractor VenturesWildwood Ventures
SpeeDx provides multiplexing technology platforms and diagnostic assays for detecting infectious disease pathogens, including customized solutions for respiratory infections, sexually transmitted infections, gastrointestinal illness, and antimicrobial resistance markers.
BiotechMedical Devices
Proton Intelligence develops CKM™, a continuous monitoring medical device drawing on biosensing and minimally invasive microdevice technology for clinical use.
Deep TechDigital HealthHealthtechMedical Devices
Co-investors15th RockAIN VenturesLongeVC
Proxima Bio is an early-stage biotechnology company developing protein degradation technology to target previously undruggable proteins for treatment of autoimmune conditions and cancers.
BiotechHealthtechMedical DevicesMelbourne, AU
Jase(Co-founder)Jon(Co-founder)John McFarland(Executive Officer)Zachary Carpenter(Executive Officer, Director)
BoardJason Pontin(Director)inAlex Gasner(Director)
Co-investorsTin Alley VenturesDCVC (Data Collective)
Halle Tecco(Founder)Bill Evans(Founder)in
Co-investorsFlare Capital PartnersKaiser Permanente VenturesNew Enterprise Associates (NEA)Rock Health CapitalSteelSky VenturesStorm Ventures
SpeeDx develops PCR-based diagnostic tests for sexually transmitted infections that detect pathogens and antibiotic resistance markers, enabling clinicians to make informed treatment decisions.
BiotechData & InfrastructureDigital HealthHealthtechMedical DevicesSydney, AU
Alison Todd(Co-founder)Elisa Mokany(Co-founder)in
Co-investorsNorthpond Ventures
Sweetch provides AI-driven personalized behavioral interventions that help patients manage chronic conditions through continuous engagement and adaptive recommendations.
AI & Machine LearningDigital HealthHealthtech
Co-investorsEntrée CapitalLionBirdPontifax Venture CapitalTal VenturesOurCrowd
Syndeio Biosciences is a synapse-focused biotech developing precision neurotherapeutics for neuropsychiatric, mental health, and cognitive disorders such as depression and Alzheimer's.
AI & Machine LearningBiotechDigital Health
Co-investorsEvolution VC PartnersCatalio Capital ManagementPalo Santo
A venture capital firm that invests in the commercialization of research, with a focus on innovations emerging from the University of Melbourne and its affiliated medical research institutions and hospitals in the Melbourne Biomedical Precinct.
BiotechDeep TechImpact & Social GoodMelbourne, AU
Co-investorsAGI HOUSE VENTURESAramco VenturesBTECH CONSORTIUMEJF VenturesLakestarNotion Capital
Verge Labs builds AI models trained on multimodal human patient data to predict drug targets and patient populations for clinical development, primarily in neuroscience and central nervous system (CNS) disease.
AI & Machine LearningBiotechDeep TechDigital HealthHealthtechSan Francisco, US
Alice Zhang(Co-founder & CEO)inJason Chen(Cofounder)inEmily Ripka(Head of Product & Engineering)in
Co-investorsAgent CapitalBOLD LongevityDraper AssociatesFitz Gate VenturesGreat Oaks Venture CapitalKarlin Ventures+5 more
Other
Tracked investments with no reachable website or further public details — typically companies that wound down, renamed, or were absorbed.
CurveBeam AICuttlefishCuttlefish BioRekover TherapeuticsSyndeioXyloYosemite
Rows marked “SEC filing” are inferred from directors named on the company's SEC Form D — public regulatory data, not a portfolio list published by the firm.































































































